Perfusion Medical is a Reston-based company that is focused on commercializing PEG-20k, an innovative IV solution developed at the Virginia Commonwealth University VCU School of Medicine. PEG-20k has shown great potential in addressing severe blood loss hemorrhagic shock and related medical conditions, making it a disruptive solution in the field. The major mechanism of action of PEG-20k is to increase tissue perfusion, facilitating the rapid transfer of oxygen into oxygen-starved tissues and organs, ultimately reversing the metabolic cell and tissue swelling that occurs during shock.
With the support of over $10 million in funding from the US Army, the development of PEG-20k highlights its potential to assist both war fighters and civilians. Scientific publications have demonstrated the superior survival outcomes and increased tolerance to shock achieved with PEG-20k, positioning it as a critical new life science technology. While PEG-20k and its uses are still investigational and have not been approved by the FDA, Perfusion Medical is at the forefront of its development, aiming to bring this breakthrough solution to patients in need.
Generated from the website